Articles From: Stereotaxis and Princess Grace Hospital Share Significant New Clinical Data for Remote Magnetic Ablation Procedures to Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)


2015/1/5
Wayfair Inc. (NYSE:W), one of the world’s largest online destinations for home furnishings and décor, announced that as of December 31, 2014 the number of shares of Class A common stock outstanding was 37,002,874. This is an increase from the 12,650,000 shares of Class A common stock outstanding previously reported by Wayfair in its Form 10-Q quarterly report.
Sign-up for Wayfair Updates Class A Share Count as of December 31, 2014 investment picks
2014/12/23
BRIDGEWATER, N.J. , Dec.
Sign-up for CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement in the Kingdom of Saudi Arabia investment picks
2015/1/7
-- Domino Foods, Inc. will serve as sponsor NEW YORK , Jan.
Sign-up for Martha Bakes To Premiere Fourth Season On PBS Beginning January 10th investment picks
2014/12/25
By Silvia Ascarelli, MarketWatch NEW YORK (MarketWatch) -- Bill Gates is back with a list of his favorite reads from 2014.
Sign-up for UPDATE: The five best books Bill Gates read in 2014 investment picks
2015/1/27
WILMINGTON, Del.
Sign-up for SILICON IMAGE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2015/1/8
SAN DIEGO, Jan.
Sign-up for Otonomy Provides Corporate and Product Pipeline Update investment picks
2014/12/9
Formulated to Help Alleviate Symptoms Associated with Fibrocystic Breast Condition for the Estimated 50 Percent of Women Aged 15 to 49 Who Suffer from Monthly Breast Discomfort MENLO PARK, Calif.
Sign-up for Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* investment picks
2015/1/22
Assurant, Inc. (NYSE:AIZ), a premier provider of specialty insurance and insurance-related products and services, today announced the company is rescheduling the time of its 2014 fourth quarter and full-year earnings conference call to 9 a.m. ET, Friday, Feb.
Sign-up for Assurant 2014 Fourth Quarter and Full-Year Financial Results Conference Call Rescheduled investment picks
2015/1/15
Anworth Mortgage Asset Corporation (NYSE: ANH) announced today that, in accordance with the terms of Anworth’s 8.625% Series A Cumulative Preferred Stock, or Series A Preferred Stock, the board of directors declared a Series A Preferred Stock dividend of $0.539063 per share for the first quarter of 2015.
Sign-up for Anworth Announces Series A and Series B Preferred Stock Dividends investment picks
2014/12/15
- Dominion recognized for safety record, infrastructure investments, philanthropy, proactive environmental measures and more - Company CEO attributes success to employee work ethic RICHMOND, Va.
Sign-up for Dominion Named 2014 'Utility of the Year' by Electric Light & Power investment picks
2015/1/5
ZHANGZHOU, China , Jan.
Sign-up for China Zenix Auto Wins Supply Contract With FAW investment picks
2014/12/22
LITTLE ROCK, Ark., Dec.
Sign-up for Windstream Awarded Multimillion-Dollar Contract by the National Weather Service investment picks
2014/12/8
-- Qualcomm to showcase its chronic care management solution and provide keynote address at mHealth Summit 2014 --
Sign-up for Qualcomm announces collaboration with vitaphone e-health solutions to power high-tech, high-touch telehealth and remote monitoring services investment picks
2014/12/15
HOUSTON , Dec.
Sign-up for Baker Hughes Announces Fourth Quarter 2014 Conference Call investment picks
2015/1/15
Monitise plc (LSE: MONI), a global leader in Mobile Money solutions, today announced that it has partnered with the MoneyPass Network to offer a range of advanced Mobile Money services and card control capabilities to card issuers in the United States.
Sign-up for MoneyPass Partners with Monitise to Offer Mobile Card Services investment picks
2015/1/8
LOS ANGELES, Jan.
Sign-up for Air Lease Corporation Announces Fourth Quarter 2014 Earnings Conference Call investment picks
2015/1/28
By Sara Sjolin and Carla Mozee, MarketWatch Greek assets hit on fears Syriza could hurt bailout LONDON (MarketWatch) -- Greek stocks tanked for a third straight day on Wednesday as the country's new government started to unravel key parts of its bailout agreement, while the broader European markets fell after a mixed batch of corporate updates.
Sign-up for UPDATE: Greece's Athex stock index hits two-year low investment picks
2015/1/20
Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce that its parent company, Canon Inc., has ranked third for U.S. patent holders in 2014.
Sign-up for Canon Ranks Among Top Five U.S. Patent Holders for 29th Consecutive Year investment picks
2015/1/20
AAC Holdings, Inc. (NYSE: AAC), disclosed that on January 8, 2015, its new substance abuse outpatient center in Las Vegas, Nevada, received full licensure for intensive outpatient treatment services and has begun treating patients at the facility.
Sign-up for AAC Holdings, Inc. Provides Facility Updates in California, Florida and Nevada investment picks
2015/1/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1170291&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for PennantPark Investment Corporation Announces Preliminary Financial Estimates for December 31, 2014 investment picks
2014/12/19
Ferro Corporation (NYSE: FOE, “Company”) announced today that it has completed the sale of the majority of the assets of its Polymer Additives business to Polymer Additives, Inc., a wholly owned portfolio company of H.I.G. Capital, LLC, for approximately $154 million in cash, subject to customary working capital and other purchase price adjustments.
Sign-up for Ferro Announces the Sale of Its North America-Based Polymer Additives Business investment picks
2014/12/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165552&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment investment picks
2015/2/2
By Julie Steinberg Michael Carpenter, chief executive of auto lender Ally Financial Inc., is stepping down, the company announced on Monday.
Sign-up for Ally Financial CEO Michael Carpenter Steps Down investment picks
2015/1/20
Edison International, the parent company of Southern California Edison (SCE), reminds high school seniors that there’s still time to apply for the 2014-15 Edison Scholars Program , which offers $1.2 million in scholarships to high school seniors planning to pursue college studies in science, technology, engineering or math ( STEM ) fields.
Sign-up for Feb. 1 is Deadline to Apply for $1.2 Million Edison Scholars Program investment picks
2015/1/21
DURHAM, N.C., Jan.
Sign-up for Square 1 Financial Reports Fourth Quarter and Full Year 2014 Results investment picks
2014/12/4
Learning Tree International (NASDAQ:LTRE) LEARNING TREE INTERNATIONAL Following the issuance of Learning Tree’s Fourth Quarter 2014 Earnings Report, senior management will discuss the results and hold a question and answer session.
Sign-up for Learning Tree International Fourth Quarter 2014 Conference Call Date and Time investment picks
2015/1/6
By Dana Mattioli, Ryan Dezember and Chelsey Dulaney Coach Inc. has agreed to buy upscale shoe brand Stuart Weitzman for $574 million, a rare acquisition for the purse retailer as it seeks to expand its reach.
Sign-up for Coach to buy Stuart Weitzman for $574 million investment picks
2015/2/2
H&R Real Estate Investment Trust Announces US$125MM Private Placement of Floating Rate Senior Unsecured Debentures Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES .
Sign-up for H&R Real Estate Investment Trust Announces US$125MM Private Placement of Floating Rate Senior Unsecured Debentures investment picks
2014/12/8
95% (19/20) Overall Response Rate (ORR) in Patients with High-Risk CLL, the patient population to be studied in recently announced Phase 3 Clinical Trial being conducted under Special Protocol Assessment (SPA) 87% (34/39) ORR per iwCLL criteria in all evaluable CLL patients plus an additional 10% of patients with a nodal PR or nodal reductions ranging from 20%-45% without disease progression 88% (7/8) ORR in all evaluable Mantle Cell Lymphoma (MCL) patients with a 38% (3/8) Complete Response rate Combination of TG-1101 + Ibrutinib well tolerated with limited Grade 3/4 events reported to date SAN FRANCISCO, Dec.
Sign-up for Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL) investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Stereotaxis and Princess Grace Hospital Share Significant New Clinical Data for Remote Magnetic Ablation Procedures to Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent